Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Muhammad Hafiz Aini"'
Autor:
Muhammad Hafiz Aini, Rakhmad Hidayat, Nita Widjaya, Fhathia Avisha, Heydi Marizky Lisman, Devi Nurfadila Fani
Publikováno v:
Romanian Journal of Neurology, Vol 22, Iss 3, Pp 261-264 (2023)
Coronavirus 2 or SARS-CoV-2 is predominantly manifests as a respiratory infection; however, it has been linked to a spectrum of neurological disorders such as vertigo, cephalalgia, cognitive impairment, myalgia, and anosmia. Emerging reports indicate
Externí odkaz:
https://doaj.org/article/173ace9a940044d1bd2dac8dd5af287e
Autor:
Sharifah Shakinah, Muhammad Hafiz Aini, Rini Sekartini, Soedjatmiko, Bernie Endyarni Medise, Hartono Gunardi, Irene Yuniar, Wahyuni Indawati, Sukamto Koesnoe, Kuntjoro Harimurti, Suzy Maria, Angga Wirahmadi, Rini Mulia Sari, Lilis Setyaningsih, Fikrianti Surachman
Publikováno v:
Vaccines, Vol 12, Iss 4, p 371 (2024)
Background: COVID-19 is one of the most devastating pandemics of the 21st century. Vaccination is one of the most effective prevention methods in combating COVID-19, and one type of vaccine being developed was the protein subunit recombinant vaccine.
Externí odkaz:
https://doaj.org/article/c6e9ce83f8274dfda1e5080f62c8fe3d
Publikováno v:
Acta Medica Indonesiana, Vol 54, Iss 3 (2022)
In 2020, a new type of coronavirus (SARS-CoV-2) whose disease is called Coronavirus disease 2019 (COVID-19) has been reported. This virus was first discovered in Wuhan, China and has infected 90,308 people per March 2, 2020. As of the end of October
Externí odkaz:
https://doaj.org/article/69806924dc2a48e890e49748fb282504
Autor:
Rakhmad Hidayat, Alyssa Putri Mustika, Fhathia Avisha, Zlatikha Djuliannisaa, Dinisa Diah Winari, Ria Amiliah Putri, Heydi Marizky Lisman, Vandra Davin, Alvina Widhani, Muhammad Hafiz Aini, Meilisa Rahmadani, Novita Dwi Istanti, Astuti Giantini
Publikováno v:
Vaccines, Vol 10, Iss 6, p 877 (2022)
Facing the rising cases of with higher fatalities COVID-19, some countries decided to give the third dose of vaccine as a booster. As of 9 January 2022, 90.31% of health workers in Indonesia have received the third dose vaccine. This study aims to pr
Externí odkaz:
https://doaj.org/article/aea2f5c15445463f806b760e739d2d5d
Publikováno v:
Journal Of The Indonesian Medical Association. 71:228-233
Pendahuluan: Coronavirus disease 2019 (COVID-19) memiliki tingkat keparahan dari flu ringan hingga gagal napas dan kematian. Diabetes melitus (DM) dianggap sebagai salah satu faktor risiko kerentanan infeksi dan tingkat keparahan penyakit pada COVID-
Autor:
Rakhmad Hidayat, Zlatikha Djuliannisaa, Alyssa Putri Mustika, Gemia Clarisa Fathi, Muhammad Hafiz Aini, Wahyu Ika Wardani, Assifa Swasti Anindita, Siti Azizah, Astuti Giantini, Muhammad Arza Putra
Publikováno v:
Journal of Environmental and Public Health.
When the outbreak of the COVID-19 delta variant occurred in June 2021, there was a marked increase in Indonesia’s number of self-isolated patients. The Universitas Indonesia Hospital provided a One-Stop Service (OSS) to monitor COVID-19 patients on
Autor:
Rakhmad Hidayat, Alyssa Putri Mustika, Fhathia Avisha, Zlatikha Djuliannisaa, Dinisa Diah Winari, Ria Amiliah Putri, Heydi Marizky Lisman, Vandra Davin, Gemia Clarisa Fathi, Alvina Widhani, Muhammad Hafiz Aini, Yudhistira Yudhistira, Siti Azizah, Meilisa Rahmadani, Novita Dwi Istanti, Astuti Giantini
Publikováno v:
Acta Medica Academica. 51:69
Objective. The longevity of vaccine effectiveness and antibody titer after the Moderna mRNA COVID-19 vaccination booster in healthcare workers in Indonesia is not known.Materials and Methods. We performed a prospective observational study of healthca